Team:Fatih-Medical/Testpage

From 2012.igem.org

(Difference between revisions)
Line 21: Line 21:
     <nav>
     <nav>
             <ul class="sf-menu">
             <ul class="sf-menu">
-
                 <li class="current"><a href="index.html">About us</a><ul>
+
                 <li class="current"><a href="index.html">Home</a></li>
-
                        <li><a href="more.html">Company</a><ul>
+
                <li><a href="index-1.html">Team</a></li>
-
                                <li><a href="more.html">Our Team</a></li>
+
                <li><a href="index-2.html">Survey</a></li>
-
                                <li><a href="more.html">What We Do</a></li>
+
                 <li><a href="index-3.html">Project</a></li>
-
                            </ul>
+
                 <li><a href="index-4.html">Parts</a></li>
-
                        </li>
+
                 <li><a href="index-5.html">Modelling</a></li>
-
                        <li><a href="more.html">Latest News</a></li>
+
                 <li><a href="index-5.html">Safety</a></li>              
-
                        <li><a href="more.html">Contacts</a></li>
+
                 <li><a href="index-5.html">Attributions</a></li>
-
                    </ul>
+
 
-
                </li>
+
-
                 <li><a href="index-1.html">Services</a></li>
+
-
                 <li><a href="index-2.html">Solutions</a></li>
+
-
                 <li><a href="index-3.html">Support</a></li>
+
-
                 <li><a href="index-4.html">Training</a></li>
+
-
                 <li><a href="index-5.html">Contacts</a></li>
+
             </ul>
             </ul>
             <div class="bottom"></div>
             <div class="bottom"></div>

Revision as of 09:35, 10 September 2012

StarCorp

CANCEL the CANCER: A SynBio Approach to the Early Diagnosis of Cancer


Our project is mainly based on the early diagnosis of cancer. EpCAM (Epithelial cell adhesion molecule) is a pan-epithelial differentiation antigen overexpressed on the basolateral surface of most carcinomas and Circulating Tumor Cells(CTC); cells which are released into blood in early phases of cancer. Our objective is to fix appropriate antibodies for EpCAM antigens to the E.coli cell wall so that we will be able to detect CTCs before the cancer precipitates its way to metastasis. For the next step, we plan to enhance the detection signal in our bacteria by the means of the quorum sensing mechanism. Finally, to prevent the production of possible undesirable and detrimental genetically modified organisms (GMOs), we aim to induce self-destruction device in our E.coli via emission of light.



Welcome

Duis aute irure dolor in reprehendeit invoptate sit nvelit esse cillum dolore fumgiat officia desemrunt mollit. Anim in laborum excepteur sint occaecat.

Duis aute irure dolor in repreheder invoptate velit cillum dolore inugiat officia deserunt molit anim in laborum excepteur sint occaiecat cupidatan oin proident. Sunt in culpa qui officia deserunt.ollit anim.

Best Services for You!

Market Assessment

Duis aute irure dolor in reprehendeit invoptate sit nvelit esse cillum dolore fumgiat officia desemrunt mollit laborum.

Learn More

Business Planning

Duis aute irure dolor in reprehendeit invoptate sit nvelit esse cillum dolore fumgiat officia desemrunt mollit laborum.

Learn More

Support Center

Duis aute irure dolor in reprehendeit invoptate sit nvelit esse cillum dolore fumgiat officia desemrunt mollit laborum.

Learn More

Retrieved from "http://2012.igem.org/Team:Fatih-Medical/Testpage"